Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Imigran Recovery
Active Ingredient: Sumatriptan succinate 70mg equivalent to sumatriptan base 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Product: Luxyal Monodose
Active Ingredient: Sodium hyaluronate 1.5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Pharma Stulln GmbH, Stulln, Germany
Product: Luxyal
Active Ingredient: Sodium hyaluronate 1.5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Tubilux Pharma SpA, Pomezia, Rome, Italy
Product: Nicotinell TTS 10
Active Ingredient: Nicotine 17.5mg (7mg/24hr)
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturer: LTS Lohmann Therapie-Systeme AG, Andernach, Germany
Product: Nicotinell TTS 20
Active Ingredient: Nicotine 35mg (14mg/24h)
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturer: LTS Lohmann Therapie-Systeme AG, Andernach, Germany
Product: Nicotinell TTS 30
Active Ingredient: Nicotine 52.5mg (21mg/24h)
Dosage Form: Transdermal patch
New Zealand Sponsor: Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturer: LTS Lohmann Therapie-Systeme AG, Andernach, Germany
Dated this 20th day of March 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).